This form does not yet contain any fields.

    17th EMIG BD Meeting

    The 17th EMIG BD meeting took place at the Manor at Weston on the Green, Oxfordshire on the 20th March 2014.  The meeting was oversubscribed with over 40 companies represented. Key speakers and contributors included: Adam Minshall of Besins Healthcare introducing their new UK subsidiary and  Janit Patel of Auden Mckenzie showcasing the firms history and BD strategy

    Dr Vjera Magdalenic-Moussavi of Imperial College illustrated how industry can engage with Imperial and Simon Coates Walker of Consilient Health and Charles Joynson of Wavedata headed up a discussion on the UK drug Tariff.  

    The new 2014 format was well received and plenty of relaxed networking took place over lunch and dinner. We look forward to welcoming our members to the 18th meeting on the 19th June.


    Europharm SMC Presentation

    Andrew Dean of Present Value presented the UK business development landscape at the Joint EMIG/Europharm SMC/ AMLIS conference held on the 6th & 7th March at the Bloomsbury Hotel in London.

    This inaugral conference brought together small to medium pharmaceutical firms from across Europe.


    16th EMIG Business Development Meeting

    The 16th EMIG Business Development meeting took place on the 5th December at the Manor, Weston on the Green.  After a networking lunch and a chairman’s welcome from Andrew SM Dean sessions kicked off with Biocodex’s Vice president of business development giving a fascinating presentation on the French group and their international expansion. Nick Craig, associate director of Finance presented an update on Actavis and their specialty brand division Warner Chilcott.   In an interesting diversion, Justin Block a bespoke tailor, presented on correct attire and the art of a good suit.  This session prompted lively discussion.  After a long networking break Datapharm’s CEO Larry Berry and Executive Director Mike Delaney presented on their novel i4Health platform which assists industry in interrogating and making sense of the myriad of NHS data available.  Prior to the meeting past delegates were surveyed on the quality and future direction of these meetings. Andrew Dean, presented the results, which were generally very positive. Delegates were then invited to offer further suggestions, following reflection of the data and their experiences.  A number of suggestions were carried and will be incorporated into the 2014 meetings.  Finally Leslie Galloway updated the group on the latest PPRS. The day ended with a relaxed dinner and quality networking continued. 2014 dates will be published soon. Presentations are available for download from


    15th EMIG Business Development Meeting

    The 15th EMIG Business development group meeting took place at the Manor at Weston on the Green on the 3rd October 2013.

    The day kicked off with Guy Clark presenting the Amdipharm Mercury Company and their growth trajectory with Cinven. Colin Love then presented the importance of alliance management in the context of AMCo’s Fucithalmic acquisition.   Daiichi Sankyo was showcased by Lak Sahota and Stuart Richards of Pinsent Masons examined new aspects of competition law.

    Leslie Galloway updated the group on Value based pricing and the imminent changes expected. The sessions ended with lively descriptions of the roller coaster MBO process by David Trevor and Jim Keeling.  The meeting was very well attended with good networking opportunities at lunch, coffee and dinner.  The next event will take place on 5th December 2013.


    13th EMIG Business development group meeting

    The 13th EMIG Business development group meeting took place at the Manor at Weston on the Green on the 21st March 2013.

    The meeting now has an enhanced format with dual presentations from Pharma companies and Specialist service providers.  This took the form of real world business scenario’s where both companies presented on best practice and solutions implemented. Topics included understanding parallel trade, getting the most out of BioEurope and how to navigate an SMC submission.

    Lundbeck, Present Value, Warner Chilcott, Nordic Pharma, Roboleo and Clarity Pharma presented.

    Other companies showcased were Teva UK Limited and the new team at Pinsent Masons.

    Finally Leslie Galloway presented the latest VBP position and EMIG’s view.

    The meeting was oversubscribed with lively networking at lunch, coffee and dinner.

    The next event will take place on June 20th.